Zejuan Li lab Publications
5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer
Shao, J, Xu, Y, Olsen, RJ, Kasparian, S, Sun, K, Mathur, S, Zhang, J, He, C, Chen, SH, Bernicker, EH & Li, Z 2024, , Cells, vol. 13, no. 8, 715. https://doi.org/10.3390/cells13080715
Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis
Shao, J, Olsen, RJ, Kasparian, S, He, C, Bernicker, EH & Li, Z 2024, , Cells, vol. 13, no. 4, 298. https://doi.org/10.3390/cells13040298
Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia
Shao, J, Shah, S, Ganguly, S, Zu, Y, He, C & Li, Z 2023, , Clinical Epigenetics, vol. 15, no. 1, 134. https://doi.org/10.1186/s13148-023-01547-0
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal
Li, Y, Xue, M, Deng, X, Dong, L, Nguyen, LXT, Ren, L, Han, L, Li, C, Xue, J, Zhao, Z, Li, W, Qing, Y, Shen, C, Tan, B, Chen, Z, Leung, K, Wang, K, Swaminathan, S, Li, L, Wunderlich, M, Mulloy, JC, Li, X, Chen, H, Zhang, B, Horne, D, Rosen, ST, Marcucci, G, Xu, M, Li, Z, Wei, M, Tian, J, Shen, B, Su, R & Chen, J 2023, , Cell Stem Cell, vol. 30, no. 8, pp. 1072-1090.e10. https://doi.org/10.1016/j.stem.2023.07.001
Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine
Shao, J, Shah, S, Ganguly, S, Zu, Y, He, C & Li, Z 2023, , Genes, vol. 14, no. 6, 1180. https://doi.org/10.3390/genes14061180
Cell-free DNA 5-hydroxymethylcytosine as a marker for common cancer detection
Shao, J, Bernicker, EH, He, C & Li, Z 2022, , Clinical and Translational Discovery, vol. 2, no. 4, e136. https://doi.org/10.1002/ctd2.136
Cell-free DNA 5-hydroxymethylcytosine as a marker for common cancer detection
Shao, J, Bernicker, EH, He, C & Li, Z 2022, , Clinical and Translational Discovery, vol. 2, no. 4, e136. https://doi.org/10.1002/ctd2.136
Revision of RUNX1 variant curation rules
the Myeloid Malignancy Variant Curation Expert Panel 2022, , Blood Advances, vol. 6, no. 16, pp. 4726-4730. https://doi.org/10.1182/bloodadvances.2022008017
Exome sequencing identifies PD-L2 as a potential predisposition gene for lymphoma
Shao, J, Gao, L, Leung, ML, Gallinger, B, Inglese, C, Meyn, MS, Del Gaudio, D, Das, S & Li, Z 2022, , Hematological Oncology, vol. 40, no. 3, pp. 475-478. https://doi.org/10.1002/hon.3033
Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia
Shao, J, Wang, S, West-Szymanski, D, Karpus, J, Shah, S, Ganguly, S, Smith, J, Zu, Y, He, C & Li, Z 2022, , Scientific Reports, vol. 12, no. 1, 12410, pp. 12410. https://doi.org/10.1038/s41598-022-16685-3
Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia
Wu, TM, Xue, SL, Li, Z, Yu, JQ, Wang, J, Wang, BR, Wan, CL, Shen, XD, Qiu, QC, Bao, XB & Wu, DP 2021, , Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, vol. 42, no. 8, pp. 646-653. https://doi.org/10.3760/cma.j.issn.0253-2727.2021.08.006
Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia
Wu, TM, Xue, SL, Li, Z, Yu, JQ, Wang, J, Wang, BR, Wan, CL, Shen, XD, Qiu, QC, Bao, XB & Wu, DP 2021, , Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, vol. 42, no. 8, pp. 646-653. https://doi.org/10.3760/cma.j.issn.0253-2727.2021.08.006
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Qing, Y, Dong, L, Gao, L, Li, C, Li, Y, Han, L, Prince, E, Tan, B, Deng, X, Wetzel, C, Shen, C, Gao, M, Chen, Z, Li, W, Zhang, B, Braas, D, ten Hoeve, J, Sanchez, GJ, Chen, H, Chan, LN, Chen, CW, Ann, D, Jiang, L, Müschen, M, Marcucci, G, Plas, DR, Li, Z, Su, R & Chen, J 2021, , Molecular Cell, vol. 81, no. 5, pp. 922-939.e9. https://doi.org/10.1016/j.molcel.2020.12.026
Identifying possible germline variants from tumor-only sequencing of hematological malignancies
Shao, J, Subedi, S, Pepper, K, Badgett, S, Christensen, PA, Hendrickson, HL, Thomas, JS, Olsen, RJ & Li, Z 2021, , Leukemia and Lymphoma, vol. 62, no. 2, pp. 482-485. https://doi.org/10.1080/10428194.2020.1832665
Germline variants drive myelodysplastic syndrome in young adults
Feurstein, S, Churpek, JE, Walsh, T, Keel, S, Hakkarainen, M, Schroeder, T, Germing, U, Geyh, S, Heuser, M, Thol, F, Pohlkamp, C, Haferlach, T, Gao, J, Owen, C, Goehring, G, Schlegelberger, B, Verma, D, Krause, DS, Gao, G, Cronin, T, Gulsuner, S, Lee, M, Pritchard, CC, Subramanian, HP, del Gaudio, D, Li, Z, Das, S, Kilpivaara, O, Wartiovaara-Kautto, U, Wang, ES, Griffiths, EA, Döhner, K, Döhner, H, King, MC & Godley, LA 2021, , Leukemia, vol. 35, no. 8, pp. 2439-2444. https://doi.org/10.1038/s41375-021-01137-0
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations
Feurstein, S, Adegunsoye, A, Mojsilovic, D, Vij, R, West DePersia, AH, Rajagopal, PS, Osman, A, Collins, RH, Kim, RH, Gore, SD, Greenberg, P, Godley, LA, Li, Z, Del Gaudio, D, Subramanian, HP, Das, S, Walsh, T, Gulsuner, S, Segal, JP, Husain, AN, Gurbuxani, S, King, MC, Strek, ME & Churpek, JE 2020, , Blood Advances, vol. 4, no. 19, pp. 4883-4886. https://doi.org/10.1182/BLOODADVANCES.2020001721
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Su, R, Dong, L, Li, Y, Gao, M, Han, L, Wunderlich, M, Deng, X, Li, H, Huang, Y, Gao, L, Li, C, Zhao, Z, Robinson, S, Tan, B, Qing, Y, Qin, X, Prince, E, Xie, J, Qin, H, Li, W, Shen, C, Sun, J, Kulkarni, P, Weng, H, Huang, H, Chen, Z, Zhang, B, Wu, X, Olsen, MJ, Müschen, M, Marcucci, G, Salgia, R, Li, L, Fathi, AT, Li, Z, Mulloy, JC, Wei, M, Horne, D & Chen, J 2020, , Cancer Cell, vol. 38, no. 1, pp. 79-96.e11. https://doi.org/10.1016/j.ccell.2020.04.017
Development and validation of Houston Methodist Variant Viewer version 3: Updates to our application for interpretation of next-generation sequencing data
Christensen, PA, Subedi, S, Pepper, K, Hendrickson, HL, Li, Z, Thomas, JS, Wesley Long, S & Olsen, RJ 2020, , JAMIA Open, vol. 3, no. 2, pp. 299-305. https://doi.org/10.1093/jamiaopen/ooaa004
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
Luo, X, Feurstein, S, Mohan, S, Porter, CC, Jackson, SA, Keel, S, Chicka, M, Brown, AL, Kesserwan, C, Agarwal, A, Luo, M, Li, Z, Ross, JE, Baliakas, P, Pineda-Alvarez, D, DiNardo, CD, Bertuch, AA, Mehta, N, Vulliamy, T, Wang, Y, Nichols, KE, Malcovati, L, Walsh, MF, Rawlings, LH, McWeeney, SK, Soulier, J, Raimbault, A, Routbort, MJ, Zhang, L, Ryan, G, Speck, NA, Plon, SE, Wu, D & Godley, LA 2019, , Blood Advances, vol. 3, no. 20, pp. 2962-2979. https://doi.org/10.1182/bloodadvances.2019000644
Somatic mutation panels: Time to clear their names
Trottier, AM, Cavalcante de Andrade Silva, M, Li, Z & Godley, LA 2019, , Cancer Genetics, vol. 235-236, pp. 84-92. https://doi.org/10.1016/j.cancergen.2019.04.065